Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.

Mol Cell Proteomics · 2009 · PMC2690491 · PMID 19329653

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendp < 0.1so close (0.05 < p ≤ 0.1)

6 C ), occludin (OCLN), splice isoform 1 of surfeit locus protein 4 (SURF4), thioredoxin domain-containing protein 5 precursor (TXNDC5), and ubiquitin and ribosomal protein S27A (RP27A) showed a trend toward differential abundance (0.05 < p < 0.1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.